Effect of estrogen depletion on pain sensitivity in aromatase inhibitor-treated women with early-stage breast cancer

Journal of Pain

Volumn 15, Issue 5, 2014, Pages 468-475

  Henry, N Lynn ^a   Conlon, Anna ^b   Kidwell, Kelley M ^b   Griffith, Kent ^b   Smerage, Jeffrey B ^a   Schott, Anne F ^a   Hayes, Daniel F ^a   Williams, David A ^c   Clauw, Daniel J ^c   Harte, Steven E ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

aromatase inhibitor; breast cancer; conditioned pain modulation; estrogen deprivation; Pain threshold

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; ESTROGEN; EXEMESTANE; LETROZOLE; TAMOXIFEN; TAXANE DERIVATIVE; ANALGESIC AGENT; ESTRADIOL;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONDITIONED PAIN MODULATION ASSESSMENT; DEPRESSION; DRUG WITHDRAWAL; ESTRADIOL BLOOD LEVEL; EXPERIMENTAL PAIN TEST; FATIGUE; FEMALE; HUMAN; MIDDLE AGED; MUSCULOSKELETAL DISEASE; NOCICEPTION; PAIN; PAIN THRESHOLD; PRESSURE; PRESSURE PAIN TESTING; PROSPECTIVE STUDY; RISK; SLEEP DISORDER; BLOOD; BREAST TUMOR; DEFICIENCY; DRUG EFFECTS; PAIN MEASUREMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; STIMULATION; TREATMENT OUTCOME;

ADULT; AGED; ANALGESICS; AROMATASE INHIBITORS; BREAST NEOPLASMS; ESTRADIOL; ESTROGENS; FEMALE; HUMANS; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; PHYSICAL STIMULATION; PRESSURE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84899909917     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2014.01.487     Document Type: Article

References (40)

1. K. Briot, M. Tubiana-Hulin, L. Bastit, I. Kloos, and C. Roux Effect of a switch of aromatase inhibitors on musculoskeletal symptoms in postmenopausal women with hormone-receptor-positive breast cancer: The ATOLL (Articular Tolerance of Letrozole) study Breast Cancer Res Treat 120 2010 127 134
2. H.J. Burstein, A.A. Prestrud, J. Seidenfeld, H. Anderson, T.A. Buchholz, N.E. Davidson, K.E. Gelmon, S.H. Giordano, C.A. Hudis, J. Malin, E.P. Mamounas, D. Rowden, A.J. Solky, M.R. Sowers, V. Stearns, E.P. Winer, M.R. Somerfield, and J.J. Griggs American Society of Clinical Oncology clinical practice guideline: Update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer J Clin Oncol 28 2010 3784 3796
3. K.D. Crew, H. Greenlee, J. Capodice, G. Raptis, L. Brafman, D. Fuentes, A. Sierra, and D.L. Hershman Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer J Clin Oncol 25 2007 3877 3883
4. J.M. Dixon, L. Renshaw, O. Young, J. Murray, E.J. Macaskill, M. McHugh, E. Folkerd, D.A. Cameron, R.P. A'Hern, and M. Dowsett Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancer J Clin Oncol 26 2008 1671 1676
5. M. Dowsett, J. Cuzick, J. Ingle, A. Coates, J. Forbes, J. Bliss, M. Buyse, M. Baum, A. Buzdar, M. Colleoni, C. Coombes, C. Snowdon, M. Gnant, R. Jakesz, M. Kaufmann, F. Boccardo, J. Godwin, C. Davies, and R. Peto Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen J Clin Oncol 28 2010 509 518
6. D.T. Felson, and S.R. Cummings Aromatase inhibitors and the syndrome of arthralgias with estrogen deprivation Arthritis Rheum 52 2005 2594 2598
7. B.R. Foerster, M. Petrou, R.E. Harris, P.B. Barker, E.G. Hoeffner, D.J. Clauw, and P.C. Sundgren Cerebral blood flow alterations in pain-processing regions of patients with fibromyalgia using perfusion MR imaging AJNR Am J Neuroradiol 32 2011 1873 1878
8. J. Geisler, B. Haynes, G. Anker, M. Dowsett, and P.E. Lonning Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study J Clin Oncol 20 2002 751 757
9. M.E. Geisser, J.M. Glass, L.D. Rajcevska, D.J. Clauw, D.A. Williams, P.R. Kileny, and R.H. Gracely A psychophysical study of auditory and pressure sensitivity in patients with fibromyalgia and healthy controls J Pain 9 2008 417 422
10. M.E. Geisser, R.H. Gracely, T. Giesecke, F.W. Petzke, D.A. Williams, and D.J. Clauw The association between experimental and clinical pain measures among persons with fibromyalgia and chronic fatigue syndrome Eur J Pain 11 2007 202 207
11. J. Giesecke, B.D. Reed, H.K. Haefner, T. Giesecke, D.J. Clauw, and R.H. Gracely Quantitative sensory testing in vulvodynia patients and increased peripheral pressure pain sensitivity Obstet Gynecol 104 2004 126 133
12. T. Giesecke, R.H. Gracely, M.A. Grant, A. Nachemson, F. Petzke, D.A. Williams, and D.J. Clauw Evidence of augmented central pain processing in idiopathic chronic low back pain Arthritis Rheum 50 2004 613 623
13. T. Giesecke, R.H. Gracely, D.A. Williams, M.E. Geisser, F.W. Petzke, and D.J. Clauw The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort Arthritis Rheum 52 2005 1577 1584
14. T. Giesecke, D.A. Williams, R.E. Harris, T.R. Cupps, X. Tian, T.X. Tian, R.H. Gracely, and D.J. Clauw Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors Arthritis Rheum 48 2003 2916 2922
15. R.H. Gracely, L. Lota, D.J. Walter, and R. Dubner A multiple random staircase method of psychophysical pain assessment Pain 32 1988 55 63
16. A.L. Hassett, E. Epel, D.J. Clauw, R.E. Harris, S.E. Harte, A. Kairys, S. Buyske, and D.A. Williams Pain is associated with short leukocyte telomere length in women with fibromyalgia J Pain 13 2012 959 969
17. R.D. Hays, and A.L. Stewart Sleep measures A.L. Stewart, J.E. Ware, Measuring Functioning and Well-Being: The Medical Outcomes Study Approach 1992 Duke University Press Durham, NC 235 259
18. B. Hellstrom, and U.M. Anderberg Pain perception across the menstrual cycle phases in women with chronic pain Percept Mot Skills 96 2003 201 211
19. N.L. Henry, F. Azzouz, Z. Desta, L. Li, A.T. Nguyen, S. Lemler, J. Hayden, K. Tarpinian, E. Yakim, D.A. Flockhart, V. Stearns, D.F. Hayes, and A.M. Storniolo Predictors of aromatase inhibitor discontinuation due to treatment-emergent symptoms in early-stage breast cancer J Clin Oncol 30 2012 936 942
20. N.L. Henry, M. Banerjee, M. Wicha, C. Van Poznak, J.B. Smerage, A.F. Schott, J.J. Griggs, and D.F. Hayes Pilot study of duloxetine for treatment of aromatase inhibitor-associated musculoskeletal symptoms Cancer 117 2011 5469 5475
21. N.L. Henry, J.T. Giles, and V. Stearns Aromatase inhibitor-associated musculoskeletal symptoms: Etiology and strategies for management Oncology 22 2008 1401 1408
22. N.L. Henry, T.C. Skaar, J. Dantzer, L. Li, K. Kidwell, C. Gersch, A.T. Nguyen, J.M. Rae, Z. Desta, S. Oesterreich, S. Philips, J.S. Carpenter, A.M. Storniolo, V. Stearns, D.F. Hayes, and D.A. Flockhart Genetic associations with toxicity-related discontinuation of aromatase inhibitor therapy for breast cancer Breast Cancer Res Treat 138 2013 807 816
23. L. LeResche, L. Mancl, J.J. Sherman, B. Gandara, and S.F. Dworkin Changes in temporomandibular pain and other symptoms across the menstrual cycle Pain 106 2003 253 261
24. V. Napadow, L. LaCount, K. Park, S. As-Sanie, D.J. Clauw, and R.E. Harris Intrinsic brain connectivity in fibromyalgia is associated with chronic pain intensity Arthritis Rheum 62 2010 2545 2555
25. V. Napadow, J. Lee, J. Kim, S. Cina, Y. Maeda, R. Barbieri, R.E. Harris, N. Kettner, and K. Park Brain correlates of phasic autonomic response to acupuncture stimulation: An event-related fMRI study Hum Brain Mapp 34 2013 2592 2606
26. F. Petzke, D.J. Clauw, K. Ambrose, A. Khine, and R.H. Gracely Increased pain sensitivity in fibromyalgia: Effects of stimulus type and mode of presentation Pain 105 2003 403 413
27. F. Petzke, R.E. Harris, D.A. Williams, D.J. Clauw, and R.H. Gracely Differences in unpleasantness induced by experimental pressure pain between patients with fibromyalgia and healthy controls Eur J Pain 9 2005 325 335
28. K. Phillips, and D.J. Clauw Central pain mechanisms in the rheumatic diseases: Future directions Arthritis Rheum 65 2013 291 302
29. L.S. Radloff The CES-D scale: A self-report depression scale for research in the general population J Appl Psychol Meas 1 1977 385 401
30. R.J. Santen, L. Demers, S. Ohorodnik, J. Settlage, P. Langecker, D. Blanchett, P.E. Goss, and S. Wang Superiority of gas chromatography/tandem mass spectrometry assay (GC/MS/MS) for estradiol for monitoring of aromatase inhibitor therapy Steroids 72 2007 666 671
31. M. Seidenberg, A. Haltiner, M.A. Taylor, B.B. Hermann, and A. Wyler Development and validation of a Multiple Ability Self-Report Questionnaire J Clin Exp Neuropsychol 16 1994 93 104
32. I. Sestak, J. Cuzick, F. Sapunar, R. Eastell, J.F. Forbes, A.R. Bianco, and A.U. Buzdar Risk factors for joint symptoms in patients enrolled in the ATAC trial: A retrospective, exploratory analysis Lancet Oncol 9 2008 866 872
33. E.M. Smets, B. Garssen, B. Bonke, and J.C. De Haes The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue J Psychosom Res 39 1995 315 325
34. E.M. Smith, H. Pang, C. Cirrincione, S. Fleishman, E.D. Paskett, T. Ahles, L.R. Bressler, C.E. Fadul, C. Knox, N. Le-Lindqwister, P.B. Gilman, and C.L. Shapiro Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: A randomized clinical trial J Am Med Assoc 309 2013 1359 1367
35. Y.R. Smith, C.S. Stohler, T.E. Nichols, J.A. Bueller, R.A. Koeppe, and J.K. Zubieta Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women J Neurosci 26 2006 5777 5785
36. K.L. Spritzer, and R.D. Hays MOS Sleep Scale: A Manual for Use and Scoring, Version 1.0 2003 Rand Los Angeles, CA
37. I. Tracey Can neuroimaging studies identify pain endophenotypes in humans? Nat Rev Neurol 7 2011 173 181
38. C.J. Woolf Central sensitization: Implications for the diagnosis and treatment of pain Pain 152 2011 S2 S15
39. D. Yarnitsky, Y. Crispel, E. Eisenberg, Y. Granovsky, A. Ben-Nun, E. Sprecher, L.A. Best, and M. Granot Prediction of chronic post-operative pain: Pre-operative DNIC testing identifies patients at risk Pain 138 2008 22 28
40. D. Yarnitsky, M. Granot, H. Nahman-Averbuch, M. Khamaisi, and Y. Granovsky Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy Pain 153 2012 1193 1198